RSLS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Reshape Lifesciences Inc (RSLS).


$3.18M Market Cap.

As of 04/07/2025 5:00 PM ET (MRY) • Disclaimer

RSLS Market Cap. (MRY)


RSLS Shares Outstanding (MRY)


RSLS Assets (MRY)


Total Assets

$4.79M

Total Liabilities

$5.05M

Total Investments

$0

RSLS Income (MRY)


Revenue

$8.01M

Net Income

-$7.13M

Operating Expense

$12.79M

RSLS Cash Flow (MRY)


CF Operations

-$4.43M

CF Investing

$0

CF Financing

$677.00K

RSLS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RSLS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$4,793,000 (-55.05%)

$10,663,000 (-4.30%)

$11,142,000 (-78.79%)

$52,531,000 (41.74%)

Assets Current

$4,588,000 (-55.44%)

$10,296,000 (3.88%)

$9,911,000 (-66.89%)

$29,938,000 (234.73%)

Assets Non-Current

$205,000 (-44.14%)

$367,000 (-70.19%)

$1,231,000 (-94.55%)

$22,593,000 (-19.65%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$260,000 (-98.75%)

$20,827,000 (-22.93%)

Shareholders Equity

-$253,000 (-103.80%)

$6,663,000 (82.00%)

$3,661,000 (-91.74%)

$44,334,000 (206.00%)

Property Plant & Equipment Net

$154,000 (-50.32%)

$310,000 (-64.33%)

$869,000 (-49.48%)

$1,720,000 (63.97%)

Cash & Equivalents

$793,000 (-82.61%)

$4,559,000 (15.27%)

$3,955,000 (-82.66%)

$22,815,000 (658.73%)

Accumulated Other Comprehensive Income

-$104,000 (-18.18%)

-$88,000 (0.00%)

-$88,000 (4.35%)

-$92,000 (23.97%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,460,000 (-34.24%)

$3,741,000 (3.60%)

$3,611,000 (20.25%)

$3,003,000 (33.82%)

Trade & Non-Trade Receivables

$987,000 (-40.51%)

$1,659,000 (-23.90%)

$2,180,000 (-22.56%)

$2,815,000 (7.44%)

Trade & Non-Trade Payables

$2,208,000 (30.73%)

$1,689,000 (-12.31%)

$1,926,000 (-44.46%)

$3,468,000 (-5.12%)

Accumulated Retained Earnings (Deficit)

-$642,704,000 (-1.12%)

-$635,574,000 (-1.82%)

-$624,187,000 (-8.00%)

-$577,973,000 (-12.27%)

Tax Assets

$22,000 (-21.43%)

$28,000 (-50.00%)

$56,000 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$367,000 (-40.33%)

Total Debt

$967,000 (269.08%)

$262,000 (53.22%)

$171,000 (-38.71%)

$279,000 (-97.89%)

Debt Current

$926,000 (734.23%)

$111,000 (-35.09%)

$171,000 (-38.71%)

$279,000 (-92.89%)

Debt Non-Current

$41,000 (-72.85%)

$151,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$5,046,000 (26.15%)

$4,000,000 (-46.53%)

$7,481,000 (-8.73%)

$8,197,000 (-63.69%)

Liabilities Current

$4,985,000 (31.98%)

$3,777,000 (-49.51%)

$7,481,000 (-0.65%)

$7,530,000 (-35.11%)

Liabilities Non-Current

$61,000 (-72.65%)

$223,000 (0%)

$0 (0%)

$667,000 (-93.92%)

RSLS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$8,006,000 (-7.74%)

$8,678,000 (-22.79%)

$11,240,000 (-17.35%)

$13,600,000 (20.36%)

Cost of Revenue

$2,949,000 (-5.78%)

$3,130,000 (-29.47%)

$4,438,000 (-15.50%)

$5,252,000 (4.27%)

Selling General & Administrative Expense

$9,922,000 (-44.48%)

$17,872,000 (-42.98%)

$31,343,000 (-5.63%)

$33,212,000 (118.20%)

Research & Development Expense

$1,803,000 (-22.12%)

$2,315,000 (-8.75%)

$2,537,000 (7.09%)

$2,369,000 (-32.28%)

Operating Expenses

$12,785,000 (-38.92%)

$20,931,000 (-60.62%)

$53,153,000 (-19.74%)

$66,230,000 (253.81%)

Interest Expense

$0 (0%)

-$26,000 (-123.01%)

$113,000 (-86.42%)

$832,000 (-59.39%)

Income Tax Expense

$39,000 (-25.00%)

$52,000 (113.68%)

-$380,000 (-38.69%)

-$274,000 (-51.38%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,130,000 (37.38%)

-$11,387,000 (75.36%)

-$46,214,000 (26.81%)

-$63,146,000 (-191.94%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$7,130,000 (37.38%)

-$11,387,000 (75.36%)

-$46,214,000 (26.81%)

-$63,146,000 (-191.94%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$7,130,000 (37.38%)

-$11,387,000 (75.36%)

-$46,214,000 (26.81%)

-$63,146,000 (-191.94%)

Weighted Average Shares

$515,566 (-91.34%)

$5,956,549 (1303.56%)

$424,390 (94.21%)

$218,522 (179.82%)

Weighted Average Shares Diluted

$515,566 (-91.34%)

$5,956,549 (1303.56%)

$424,390 (94.21%)

$218,522 (179.82%)

Earning Before Interest & Taxes (EBIT)

-$7,091,000 (37.58%)

-$11,361,000 (75.56%)

-$46,481,000 (25.73%)

-$62,588,000 (-216.71%)

Gross Profit

$5,057,000 (-8.85%)

$5,548,000 (-18.44%)

$6,802,000 (-18.52%)

$8,348,000 (33.31%)

Operating Income

-$7,728,000 (49.76%)

-$15,383,000 (66.81%)

-$46,351,000 (19.92%)

-$57,882,000 (-364.65%)

RSLS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

-$10,000 (89.13%)

-$92,000 (-104.96%)

$1,855,000 (177.62%)

Net Cash Flow from Financing

$677,000 (-96.15%)

$17,574,000 (461.47%)

$3,130,000 (-90.60%)

$33,299,000 (200.67%)

Net Cash Flow from Operations

-$4,427,000 (73.90%)

-$16,960,000 (22.56%)

-$21,902,000 (-42.45%)

-$15,375,000 (-79.82%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,766,000 (-723.51%)

$604,000 (103.20%)

-$18,860,000 (-195.21%)

$19,808,000 (89936.36%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$2,207,000 (210.35%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$10,000 (89.13%)

-$92,000 (73.86%)

-$352,000 (9.74%)

Issuance (Repayment) of Debt Securities

$653,000 (0%)

$0 (0%)

$0 (0%)

-$12,734,000 (-222.49%)

Issuance (Purchase) of Equity Shares

$24,000 (-99.86%)

$17,574,000 (461.47%)

$3,130,000 (-93.20%)

$46,033,000 (6679.53%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$16,000 (0%)

$0 (0%)

$4,000 (-86.21%)

$29,000 (125.66%)

Share Based Compensation

$184,000 (-75.98%)

$766,000 (-63.30%)

$2,087,000 (-82.93%)

$12,227,000 (824.19%)

Depreciation Amortization & Accretion

$22,000 (-85.71%)

$154,000 (-92.85%)

$2,153,000 (9.23%)

$1,971,000 (18.24%)

RSLS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

63.20% (-1.10%)

63.90% (5.62%)

60.50% (-1.47%)

61.40% (10.83%)

Profit Margin

-89.10% (32.09%)

-131.20% (68.09%)

-411.20% (11.44%)

-464.30% (-142.58%)

EBITDA Margin

-88.30% (31.60%)

-129.10% (67.27%)

-394.40% (11.51%)

-445.70% (-178.39%)

Return on Average Equity (ROAE)

-324.00% (-72.43%)

-187.90% (2.84%)

-193.40% (-46.85%)

-131.70% (41.15%)

Return on Average Assets (ROAA)

-113.90% (-16.82%)

-97.50% (32.06%)

-143.50% (-59.44%)

-90.00% (14.61%)

Return on Sales (ROS)

-88.60% (32.31%)

-130.90% (68.34%)

-413.50% (10.15%)

-460.20% (-163.12%)

Return on Invested Capital (ROIC)

-502.30% (22.22%)

-645.80% (74.00%)

-2484.00% (-280.54%)

1375.90% (440.74%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.32 (-145.80%)

-0.13 (-111.29%)

-0.06 (78.17%)

-0.28 (65.02%)

Price to Sales Ratio (P/S)

0.29 (67.84%)

0.17 (-32.68%)

0.25 (-80.73%)

1.32 (-15.24%)

Price to Book Ratio (P/B)

-12.56 (-2653.46%)

0.49 (-44.72%)

0.89 (35.26%)

0.66 (-18.26%)

Debt to Equity Ratio (D/E)

-19.95 (-3424.17%)

0.6 (-70.63%)

2.04 (1004.32%)

0.18 (-88.13%)

Earnings Per Share (EPS)

-13.83 (-624.08%)

-1.91 (98.25%)

-108.9 (62.31%)

-288.97 (-4.32%)

Sales Per Share (SPS)

15.53 (965.82%)

1.46 (-94.50%)

26.48 (-57.44%)

62.24 (-56.98%)

Free Cash Flow Per Share (FCFPS)

-8.59 (-201.40%)

-2.85 (94.50%)

-51.83 (27.99%)

-71.97 (37.13%)

Book Value Per Share (BVPS)

-0.49 (-143.88%)

1.12 (-87.03%)

8.63 (-95.75%)

202.88 (9.36%)

Tangible Assets Book Value Per Share (TABVPS)

9.3 (419.39%)

1.79 (-93.02%)

25.64 (-82.33%)

145.08 (12.86%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.36 (-98.33%)

-0.18 (-390.32%)

0.06 (212.73%)

-0.06 (87.09%)

Asset Turnover

1.28 (72.14%)

0.74 (112.89%)

0.35 (79.90%)

0.19 (-64.73%)

Current Ratio

0.92 (-66.25%)

2.73 (105.74%)

1.32 (-66.68%)

3.98 (415.69%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$4,427,000 (73.91%)

-$16,970,000 (22.84%)

-$21,994,000 (-39.85%)

-$15,727,000 (-75.92%)

Enterprise Value (EV)

$2,526,553 (25.33%)

$2,015,929 (173.79%)

-$2,732,017 (-182.37%)

$3,316,804 (-56.97%)

Earnings Before Tax (EBT)

-$7,091,000 (37.44%)

-$11,335,000 (75.67%)

-$46,594,000 (26.53%)

-$63,420,000 (-190.77%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,069,000 (36.92%)

-$11,207,000 (74.72%)

-$44,328,000 (26.87%)

-$60,617,000 (-234.99%)

Invested Capital

-$18,000 (-100.70%)

$2,589,000 (775.98%)

-$383,000 (-123.38%)

$1,638,000 (-81.13%)

Working Capital

-$397,000 (-106.09%)

$6,519,000 (168.27%)

$2,430,000 (-89.16%)

$22,408,000 (942.09%)

Tangible Asset Value

$4,793,000 (-55.05%)

$10,663,000 (-2.01%)

$10,882,000 (-65.68%)

$31,704,000 (215.81%)

Market Capitalization

$3,178,553 (-3.09%)

$3,279,929 (0.64%)

$3,258,983 (-88.83%)

$29,165,804 (150.22%)

Average Equity

$2,200,750 (-63.69%)

$6,060,500 (-74.64%)

$23,898,000 (-50.15%)

$47,942,750 (396.05%)

Average Assets

$6,258,000 (-46.39%)

$11,673,500 (-63.74%)

$32,198,250 (-54.10%)

$70,143,000 (241.64%)

Invested Capital Average

$1,411,750 (-19.75%)

$1,759,250 (-5.99%)

$1,871,250 (141.14%)

-$4,548,750 (-192.95%)

Shares

712,680 (-94.57%)

13,135,478 (2616.59%)

483,529 (35.94%)

355,681 (586.58%)